| 000 | 01873 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516030844.0 | ||
| 264 | 0 | _c20110531 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1535-5667 | ||
| 024 | 7 |
_a10.2967/jnumed.110.081885 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCatafau, Ana M | |
| 245 | 0 | 0 |
_aContribution of SPECT measurements of D2 and 5-HT2A occupancy to the clinical development of the antipsychotic SB-773812. _h[electronic resource] |
| 260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cApr 2011 |
||
| 300 |
_a526-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDiagnostic and Statistical Manual of Mental Disorders |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImage Processing, Computer-Assisted |
| 650 | 0 | 4 | _aIodobenzenes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPiperidines |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2A _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
| 650 | 0 | 4 |
_aRisperidone _xpharmacokinetics |
| 650 | 0 | 4 |
_aSchizophrenia _xmetabolism |
| 650 | 0 | 4 |
_aTomography, Emission-Computed, Single-Photon _xmethods |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBullich, Santiago | |
| 700 | 1 | _aNucci, Gianluca | |
| 700 | 1 | _aBurgess, Clare | |
| 700 | 1 | _aGray, Frank | |
| 700 | 1 | _aMerlo-Pich, Emilio | |
| 773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 52 _gno. 4 _gp. 526-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2967/jnumed.110.081885 _zAvailable from publisher's website |
| 999 |
_c20692133 _d20692133 |
||